BRCA2 and breast cancer: Further supporting the clinical relevance of our findings, acetaldehyde treatment specifically inhibited growth of BRCA2‐deficient human tumors in xenograft models and PARP inhibitor‐resistant BRCA1‐deficient allografted mammary tumors.